相关实验视频

Updated: May 25, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

焦虑和抑郁症的孩子与刺激性肠综合征-A叙事审查

Daniela Pop^1,2, Sorin Claudiu Man^1,2, Dorin Farcău^2,3

¹Third Pediatric Discipline, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400217 Cluj-Napoca, Romania 2 Third Pediatric Department, Emergency Hospital for Children, 400217 Cluj-Napoca, Romania 3 Nursing Discipline, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400217 Cluj-Napoca, Romania.

Diagnostics (Basel, Switzerland)

|February 26, 2025

概括

儿科刺激性肠综合征 (IBS) 与焦虑和抑郁等心理因素有关,影响肠-大脑通信. 针对这些心理问题的治疗方法在治疗儿童IBS症状方面表现有前途.

科学领域:

儿科胃肠病学儿科胃肠病学
儿童心理学儿童心理学
神经胃肠病学神经胃肠病学

背景情况:

刺激性肠综合征 (IBS) 是儿童常见的功能性胃肠疾病.
心理状况,包括焦虑和抑郁,被认为是儿科IBS的潜在风险因素.
肠-大脑轴和血清素信号传递在胃肠道和心理疾病的病理生理学中起着至关重要的作用.

研究的目的:

研究儿童的心理因素 (焦虑,抑郁) 和IBS之间的遗传,病理生理和临床联系.
评估心理疗法的疗效治疗儿童群体的IBS.
突出儿童心理事件对胃肠道健康的长期影响.

主要方法:

文献综述检查了关于心理因素和儿科IBS之间的联系的研究.
对肠-大脑轴功能障碍和血清素信号传递的作用的分析.
对抗抑郁药,催眠疗法和认知行为疗法 (CBT) 等疗法的证据评估.

主要成果:

肠-大脑通信受损和血清信号的改变都与儿童的IBS和心理障碍有关.
儿童时期的心理经历可能会导致胃肠道症状持续到成年.
针对心理困扰的疗法,包括CBT和催眠疗法,证明了IBS儿童的潜在益处.

结论:

焦虑和抑郁等心理因素与儿童患上IBS的发展之间存在重要联系.
需要进一步研究标准化标准和结果措施,以巩固理解和治疗策略.
解决心理并发症对于儿童IBS的综合管理至关重要.

关键词:

焦虑是一种焦虑.孩子们的孩子们的孩子们的孩子们.抑郁抑郁症抑郁症抑郁症抑郁症刺激性肠综合征是什么意思

更多相关视频

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

相关概念视频

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...